qualifying ailments such as Crohn’s disease, AID’s /HIV, cancer, adult type II diabetes and M.S., will now be able to ask their doctors for marijuana recommendations
Thomas Hooker, the founding father of Hartford Conn, would be very proud of his little community — In their push forward toward the goal line of in-state medical marijuana cultivation and the sale of cannabis for medicinal purposes, the Connecticut Department of Consumer Protection presented Gov. Malloy with a massive 74 page document of draft regulations for the burgeoning new green industry.
Connecticut’s Consumer Protection boss, William Rubsenstein, thinks very highly of their medical cannabis model. Hoping that one day Connecticut’s medical marijuana regulations will be held up as a beacon of light for the nation. As California and 17 other states have demonstrated, cooperation between all branches of the state government is critical, in order to avoid the mixed results other MMJ states with similar laws have suffered.
As the current set of proposed rules is subject to refinement, many are hoping for completion and the subsequent presentation to the legislative review committee by early summer. By doing so, this will keep Connecticut on track for a summertime germination of medical marijuana grow operations, as well as the sales of medical marijuana in state-licensed collectives by the end of 2013 or early 2014.
The proposed rules include an all-inclusive set of guidelines for growers, doctors and patients obtaining medical certificates –and even the disposal of unused marijuana, which could be turned in to local police.
Connecticut’s sick and debilitated with qualifying ailments such as Crohn’s disease, AID’s /HIV, cancer, adult type II diabetes and M.S., will now be able to ask their doctors for marijuana recommendations which will allow them to purchase 30 days’ worth of pain relieving marijuana. Additionally any state approved marijuana patient can also elect a caregiver to secure their monthly supplies.
When Connecticut’s General Assembly past the MMJ law last year, it preceded extensive expert testimony from many doctors who testified to the beneficial properties in marijuana’s cannabinoids and the quality of life provided by pain reduction and increased appetites for chemotherapy patients.
“The draft regulations are designed to assure that truly sick patients have safe and reliable access to marijuana to treat debilitating conditions while preventing misuse and diversion of the product from its medical purpose,” Rubenstein said in a statement. “We have treated marijuana as a pharmaceutical drug and have included all the safeguards that are currently in effect for other controlled pharmaceutical drugs. Our comprehensive approach would make Connecticut a national leader in terms of regulating medical marijuana as a pharmaceutical.”
Doctors would be required to diagnose patients as having “debilitating” conditions and develop treatment plans, taking into account their medical and prescription histories, after an “in-person” physical examination. They would have to “Be of the opinion that the potential benefits of the palliative use of marijuana would likely outweigh the health risks of such use to the qualifying patient.”
Companies that want to grow marijuana for medical use have a variety of rules, including requirements that each product have a specific brand name, registered with the DCP, as well as a list of specific chemical ingredients.
Signage outside marijuana dispensaries, staffed by licensed pharmacists, would be limited to 16 inches by 18 inches, according to the draft.
Source – CT Post